FDA Urges Congress To Fix Compounding Oversight Issues
The U.S. Food and Drug Administration on Tuesday urged a group of lawmakers to clarify and expand its existing authority over drug compounders, claiming the current reactive regulatory regime cannot curb...To view the full article, register now.
Already a subscriber? Click here to view full article